What types of patients do you treat?
How do I become a patient?
In order to begin the process please contact us.
What types of therapies are offered at TRAINM?
Qualifying patients may be offered non-invasive neuromodulation and robotics-based rehabilitation, either alone or in combination.
Each patient will be individually assessed by TRAINM doctors, who will prescribe an individually tailored treatment protocol for each patient based on the patient’s condition and needs.
All therapy sessions are performed by highly skilled therapists who use robotics as an add-on for the benefit of the patients.
How long is the treatment protocol?
The length of the treatment protocol varies based on each individual patient’s condition and needs.
How long is each therapy session?
Each session lasts approximately 30 minutes.
What kinds of neuromodulation therapies are offered at TRAINM
TRAINM offers non-invasive neuromodulation-based therapies, including but not limited to transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS). Neuromodulation has been shown to prime the neurons to fire, and when followed by a learning experience, can enhance learning and performance. For example, the US Air Force Research Laboratory (AFRL) has shown that tDCS results in a 200% increase in learning for the Intelligence, Surveillance, Reconnaissance (ISR) analyst.
Is non-invasive neuromodulation pain-free and safe?
Non-invasive neuromodulation does not cause any sensation of pain and has a very strong safety profile if performed under the care of experienced doctors and when the correct patient inclusion criteria are respected.
Who can benefit from non-invasive neuromodulation?
Patients who have neurological deficits (speech, swallow, vision, motor function etc.) may benefit from neuromodulation. Research has demonstrated that neuromodulation, followed by a learning experience can improve learning and performance. Some patients will have major improvements, some will have clinically significant improvements and some will not improve. The improvements can occur even for patients who have chronic (even several years old) neurological impairment, where no further recovery would otherwise be expected. Currently there is no way of knowing in advance who the responder groups will be.
The use of upper and lower extremity robotics as an add-on to therapists has several major advantages that results in superior patient improvements:
- The average number of movements per session is 1,000 with robotics vs. 50 with a therapist (approximately 20x more per 30 minute session). As repetition is one of the most important aspects of physical therapy, robotics offer a significant advantage to the patients.
- The robotics at TRAINM have artificial intelligence and are sensor-based, allowing the patient to initiate purposeful movement and only when the patient is not able to move further, the robotics will move the patient’s affected limbs and will stop if spasticity or resistance is sensed.
- The robotics include neuro-gaming and virtual reality, further motivating and engaging the patient to work hard towards recovery, often in real-life task-specific simulations.
- All sensor-based and patient performance data is collected and analyzed, enabling the therapists to modify the therapies based on per-session patient-specific data. It also enables the patients to see the change in their performance at each session.
- Clinical data has shown that the use of robotics, as an add-on to traditional therapists, results in superior patient recoveries that are statistically significant.
What happens when patients receive neuromodulation in addition to robotics?
This multi-disciplinary approach to performance enhancement is based on the most cutting-edge human performance optimization research that has shown that while each one of neuromodulation and robotics alone results in superior performance enhancement and patient recoveries, combined, the results can be significant and life-altering for some patients, and some patients will not respond. Currently there is no way of knowing in advance who the responder groups will be.